This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (40)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Lipids and Lipid Disorders  • Review  • Alert me on articles by topic  Social Bookmarking   What's this?

Charles R. Harper, MD; Terry A. Jacobson, MD

Arch Intern Med. 1999;159:1049-1057.

A low serum high-density lipoprotein cholesterol (HDL-C) level is a potent predictor of coronary heart disease (CHD). It has been estimated that 11% of US men have isolated low HDL-C levels, and there is uncertainty regarding the management of these patients. A cause-and-effect relationship between low HDL-C levels and CHD is supported by epidemiological, animal, and human clinical studies. We reviewed the structure and function of HDL-C and its role in preventing atherosclerosis. We then suggested an approach to the patient with isolated low HDL-C that may be useful to the primary care physician. An algorithm was proposed for use in patients with existing CHD, while the decision to treat patients without CHD was based on their score on the Framingham Heart Study risk prediction chart.

From the Department of Medicine (Drs Harper and Jacobson) and Office of Health Promotion and Disease Prevention (Dr Jacobson), Emory University, Atlanta, Ga.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Prognostic and Therapeutic Significance of Low Levels of High-Density Lipoprotein Cholesterol: Current Perspectives
Antonio M. Gotto, Jr
Arch Intern Med. 1999;159(10):1038-1040.
EXTRACT | FULL TEXT  

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 1999;159(10):1146-1147.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vascular Responses to Extractable Fractions of Ilex paraguariensis in Rats Fed Standard and High-Cholesterol Diets
Stein et al.
Biol Res Nurs 2005;7:146-156.
ABSTRACT  

Intermolecular Contact between Globular N-terminal Fold and C-terminal Domain of ApoA-I Stabilizes Its Lipid-bound Conformation: STUDIES EMPLOYING CHEMICAL CROSS-LINKING AND MASS SPECTROMETRY
Bhat et al.
J. Biol. Chem. 2005;280:33015-33025.
ABSTRACT | FULL TEXT  

Niacin-ER and Lovastatin Treatment of Hypercholesterolemia and Mixed Dyslipidemia
Yim and Chong
The Annals of Pharmacotherapy 2003;37:106-115.
ABSTRACT | FULL TEXT  

Efficacy of a Therapeutic Lifestyle Change/Step 2 diet in moderately hypercholesterolemic middle-aged and elderly female and male subjects
Lichtenstein et al.
J. Lipid Res. 2002;43:264-273.
ABSTRACT | FULL TEXT  

Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part II
Shah et al.
Circulation 2001;104:2498-2502.
FULL TEXT  

Low High-Density Lipoprotein Cholesterol as a Risk Factor in Coronary Heart Disease : A Working Group Report
Gotto
Circulation 2001;103:2213-2218.
FULL TEXT  

High Density Lipoproteins and Arteriosclerosis : Role of Cholesterol Efflux and Reverse Cholesterol Transport
von Eckardstein et al.
Arterioscler. Thromb. Vasc. Bio. 2001;21:13-27.
ABSTRACT | FULL TEXT  

Predictors of postprandial triacylglycerol response in children: the Columbia University Biomarkers Study
Couch et al.
Am. J. Clin. Nutr. 2000;72:1119-1127.
ABSTRACT | FULL TEXT  

Weight cycling and high-density lipoprotein cholesterol in women: evidence of an adverse effect: A report from the NHLBI-sponsored WISE study
Olson et al.
J Am Coll Cardiol 2000;36:1565-1571.
ABSTRACT | FULL TEXT  

Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events
van Lennep et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:2408-2413.
ABSTRACT | FULL TEXT  

"The Lower the Better" in Hypercholesterolemia Therapy: A Reliable Clinical Guideline?
Jacobson
ANN INTERN MED 2000;133:549-554.
ABSTRACT | FULL TEXT  

Use of Simvastatin Treatment in Patients With Combined Hyperlipidemia in Clinical Practice
Vicari et al.
Arch Fam Med 2000;9:898-905.
ABSTRACT | FULL TEXT  

When Should Lipids Be Measured in Myocardial Infarction?
Kashyap and Kashyap
Arch Intern Med 2000;160:1377-1378.
FULL TEXT  

Gemfibrozil, nicotinic acid and combination therapy in patients with isolated hypoalphalipoproteinemia: a randomized, open-label, crossover study
Zema
J Am Coll Cardiol 2000;35:640-646.
ABSTRACT | FULL TEXT  

Prognostic and Therapeutic Significance of Low Levels of High-Density Lipoprotein Cholesterol: Current Perspectives
Gotto
Arch Intern Med 1999;159:1038-1040.
FULL TEXT